Effects of tumour necrosis factor alpha blockade on lipid profile in active rheumatoid arthritis [12]

Rheumatology

Volumn 46, Issue 10, 2007, Pages 1626-1627

  Del Porto, Flavia ^a   Lagana B ^a   Nofroni, I ^b   Tinti, F ^c   Mitterhofer, A P ^c   D'Amelio, R ^d  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Dipto di Medicina Sperimentale   (Italy)

^c Dipartimento di Medicina Clinica   (Italy)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANTIINFLAMMATORY ACTIVITY; ARTERY INTIMA; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CAROTID ARTERY; CORRELATION ANALYSIS; HUMAN; LETTER; LIPID BLOOD LEVEL; MONOTHERAPY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 34848821967     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kem195     Document Type: Letter

References (7)

1. Popa C, Netea MG, Radstake T et al. Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis. Ann Rheum Dis 2005;64:303-5.
2. Spanakis E, Sidiropoulos P, Papadakis J et al. Modest but sustained increase of serum high density lipoprotein cholesterol levels in patients with inflammatory arthritides treated with infliximab. J Rheumatol 2006;33:2440-6.
3. Popa C, van den Hoogen FH, Radstake TR et al. Modulation of lipoprotein pattern plasma concentration during long term anti-TNF therapy in patients with active rheumatoid arthritis. Ann Rheum Dis 1 May 2007[E-pub ahead of print] doi:10.1136/ard.2006.066191.
4. Sattar N, Crompton P, Cherry L et al. Effect of Tumor necrosis factor blockade on cardiovascular risk factors in psoriatic arthritis. A double-blind, placebo-controlled study. Arthritis Rheum 2007;56:831-9.
5. Del Porto F, Laganà B, Lai S et al. Response to anti-tumour necrosis factor alpha blockade is associated with reduction of carotid intima-media thickness in patients with active rheumatoid arthritis. Rheumatology (Oxford) 2007;46:111-15.
6. Palinski W, Napoli C. Unrevealing pleiotropic effects of statins on plaque rupture. Arterioscler Thromb Vasc Biol 2002;22:1745-50.
7. McCarey DW, McInnes IB, Madhok R. Trial of Atorvastatin in Rheumatoid Arthritis (TARA): Double-blind, randomised placebo-controlled trial. Lancet 2004;363: 2015-21.